Clinical Study of 68Ga Labeled HER2 Affibody Analogues
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer and Gastric Cancer
Interventions: DRUG: 68Ga labeled HER2 Affibody
Sponsor: Xijing Hospital